Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721
International Journal of Molecular Sciences · 07.07.2026 · 27 (13) · 6071
DOI: 10.3390/ijms27136071 ↗Kurz gefasst
Korrektur in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.07.2026. Verfasst von Alessio Malacrida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the original publication [...]
Autor:innen und Institutionen
- Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy.
ORCID-Profile: Guido Cavaletti, Mariarosaria Miloso
Zitieren
APA
Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., & Miloso, M. (2026). Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721. International Journal of Molecular Sciences, 27(13), 6071. https://doi.org/10.3390/ijms27136071
Vancouver
Malacrida A, Deschamps-Wright M, Rigolio R, Cavaletti G, Miloso M. Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721. International Journal of Molecular Sciences. 2026;27(13):6071. doi:10.3390/ijms27136071
BibTeX
@article{Malacrida2026,
author = {Malacrida, Alessio and Deschamps-Wright, Marie and Rigolio, Roberta and Cavaletti, Guido and Miloso, Mariarosaria},
title = {Correction: Malacrida et al. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int. J. Mol. Sci. 2023, 24, 1721},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {6071},
doi = {10.3390/ijms27136071}
}
EUVIMED